Terazosin Capsule
Product Images NDC 63187-620

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 63187-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-620-30 (Terazosin 4 mg)

Terazosin 10mg is a medication that comes in the form of capsules with a light green opaque cap and body. Each capsule contains Terazosin Hydrochloride equivalent to terazosin 10mg. It is manufactured by Jubilant Cadista Pharmaceuticals in Salisbury, MD and packaged by Proficient Rx LP. The medication should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

This is a section presenting data on mean change from baseline at various time points up to 30 months. It may be part of a report or study on a particular intervention or treatment.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

This text appears to be a graph or table with some data points and labels. It is not possible to provide a useful description without more context or information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.